Philip H Coelho Catalyst Pharmaceuticals, Inc. (CPRX) insider trading activity

Philip H Coelho is Director of CATALYST PHARMACEUTICALS, INC.. Currently has a direct ownership of 204,887 shares of CPRX, which is worth approximately $4.48 Million. The most recent transaction as insider was on May 04, 2023, when has been sold 50,000 shares (Common Stock, par value $0.001 per share) at a price of $0.79 per share, resulting in proceeds of $39,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 205K

0% 3M change

0% 12M change

Total Value Held $4.48 Million

PHILIP H COELHO Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 04 2023	BUY Exercise of conversion of derivative security	$39,500 $0.79 p/Share	50,000 Added 19.62%	204,887 Common Stock, par valu...
Feb 15 2023	BUY Exercise of conversion of derivative security	-	4,000 Added 2.52%	154,887 Common Stock, par valu...
Dec 06 2022	BUY Exercise of conversion of derivative security	-	1,334 Added 0.88%	150,887 Common Stock, par valu...
Nov 23 2022	SELL Open market or private sale	$174,482 $17.45 p/Share	9,999 Reduced 6.27%	149,553 Common Stock, par valu...
Nov 22 2022	SELL Open market or private sale	$346,017 $17.3 p/Share	20,001 Reduced 11.14%	159,552 Common Stock, par valu...
Nov 21 2022	SELL Open market or private sale	$1,066,100 $15.23 p/Share	70,000 Reduced 28.05%	179,553 Common Stock, par valu...
Sep 14 2022	SELL Open market or private sale	$315,000 $15.75 p/Share	20,000 Reduced 7.42%	249,553 Common Stock, par valu...
Sep 13 2022	SELL Open market or private sale	$157,000 $15.7 p/Share	10,000 Reduced 3.58%	269,553 Common Stock, par valu...
Aug 17 2022	BUY Exercise of conversion of derivative security	$101,200 $2.53 p/Share	40,000 Added 12.52%	279,553 Common Stock, par valu...
Dec 03 2021	BUY Exercise of conversion of derivative security	-	1,333 Added 0.55%	239,553 Common Stock, par valu...
Aug 26 2021	SELL Open market or private sale	$52,132 $5.46 p/Share	9,548 Reduced 3.85%	238,220 Common Stock, par valu...
Aug 26 2021	BUY Exercise of conversion of derivative security	$51,998 $3.12 p/Share	16,666 Added 6.3%	247,768 Common Stock, par valu...
Aug 25 2021	SELL Open market or private sale	$52,809 $5.56 p/Share	9,498 Reduced 3.95%	231,102 Common Stock, par valu...
Aug 25 2021	BUY Exercise of conversion of derivative security	$52,001 $3.12 p/Share	16,667 Added 6.48%	240,600 Common Stock, par valu...
Aug 24 2021	SELL Open market or private sale	$52,977 $5.58 p/Share	9,494 Reduced 4.07%	223,933 Common Stock, par valu...
Aug 24 2021	BUY Exercise of conversion of derivative security	$52,001 $3.12 p/Share	16,667 Added 6.66%	233,427 Common Stock, par valu...
Dec 22 2020	BUY Exercise of conversion of derivative security	-	1,333 Added 0.61%	216,760 Common Stock, par valu...

Also insider at

AMPE

Ampio Pharmaceuticals, Inc. Healthcare

PHC

Philip H Coelho

Director

Coral Gables, FL

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CPRX shares.

Notify only if

Value

Insider Trading

Get notified when an Catalyst Pharmaceuticals, Inc. insider buys or sells CPRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to CATALYST PHARMACEUTICALS, INC.

Track Activities on CPRX

Account